Repligen (RGEN) Down 10.9% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
Repligen Corporation (RGEN)
Last repligen corporation earnings: 2/20 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
repligen.com/investors
Company Research
Source: Yahoo! Finance
Will the recent negative trend continue leading up to its next earnings release, or is Repligen due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Repligen Q1 Earnings Miss, Revenues Beat Estimates Repligen reported first-quarter 2024 adjusted earnings per share of 28 cents, which missed the Zacks Consensus Estimate of 29 cents. The company had recorded adjusted earnings of 64 cents per share in the year-ago quarter. Total revenues were $151.3 million, down 17.2% year over year on a reported basis and 20% organically. Revenues, however, beat the Zacks Consensus Estimate of $150 million. The year-over-year decrease in total revenues can be attributed to the absence of COVID-related revenues and the expected decrease in revenues from protein franchisees. Quarter in Detail The company reported product revenues of $151
Show less
Read more
Impact Snapshot
Event Time:
RGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGEN alerts
High impacting Repligen Corporation news events
Weekly update
A roundup of the hottest topics
RGEN
News
- The Schall Law Firm Begins Investigation Into Claims Against Regeneron Pharmaceuticals Inc And Encourages Affected Investors To Contact ThemAccesswire
- What Is Repligen Corporation's (NASDAQ:RGEN) Share Price Doing? [Yahoo! Finance]Yahoo! Finance
- Repligen Co. (NASDAQ: RGEN) is now covered by analysts at Guggenheim. They set a "neutral" rating on the stock.MarketBeat
- Repligen (RGEN) Promotes CCO, Shares Fall on Leadership Change [Yahoo! Finance]Yahoo! Finance
- Repligen Announces CEO Transition Plan [Yahoo! Finance]Yahoo! Finance
RGEN
Earnings
- 5/1/24 - Miss
RGEN
Sec Filings
- 6/14/24 - Form 4
- 6/14/24 - Form 4
- 6/14/24 - Form 4
- RGEN's page on the SEC website